1
Missense mutations were expressed to quantify residual activity using a new assay.
2
In addition, the new assay can be completed in less than 2h.
3
Both median fluorescence intensity and background intensity were higher in the new assay.
4
This new assay was compared with commercial ELISA test kits.
5
This new assay was compared to a conventional RT-PCR on reference strains and field materials.
6
The limit of detection (LOD) and clinical performance of this new assay were evaluated.
7
Both applications show that the new assay can be applied for human pharmacokinetic studies for both drugs.
8
This new assay was used as a secondary assay to confirm hits from a high-throughput screening program.
9
Using this new assay we show that alpha-SNAP strongly stimulates transport in reactions containing limiting amounts of cytosol.
10
The new assay has been validated and is accurate, cheaper, more rapid, and less labor-intensive than DNA sequencing.
11
This new assay permits a significant decrease in labor and cost and also offers the advantage of a continuous readout.
12
The new assay is simple, inexpensive, reproducible, requires no special reagents, and should be readily adaptable to robotic HTS systems.
13
This new assay now enables straightforward large-scale screening for PSD inhibitors against pathogenic fungi, antibiotic-resistant bacteria, and neoplastic mammalian cells.
14
This work is a first step toward establishing a new assay system for toxin detection and identification by AP shape analysis.
15
We report the development of a new assay as an alternative to direct DNA sequencing to measure RNA-edited variation in tissue.
16
To increase the throughput of promoter substitutions, we have developed a new assay for testing doxycycline sensitivity, based on liquid culture using microtitre trays.
